AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

Systematic reviews seek to identify all research that meets the eligibility criteria. However,
this goal can be compromised by 'non‐reporting bias'. The convincing evidence for the …

Background Embolic strokes of undetermined source represent 20% of ischemic strokes and
are associated with a high rate of recurrence. Anticoagulant treatment with rivaroxaban, an …

Two previous pan-European consensus meetings, the 1995 and 2006 Helsingborg
meetings, were convened to review the scientific evidence and the state of current services …

Background and Purpose—This ARISTOPHANES study (Anticoagulants for Reduction in
Stroke: Observational Pooled Analysis on Health Outcomes and Experience of Patients) …

Mendelian randomisation (MR) analysis is an important tool to elucidate the causal
relevance of environmental and biological risk factors for disease. However, causal …

Objective To update the 2016 American Academy of Neurology (AAN) practice advisory for
patients with stroke and patent foramen ovale (PFO). Methods The guideline panel followed …

Atrial fibrillation (AF) is the most common cardiac arrhythmia and prevalence is predicted to
double over the next 30 years due to changing demographics and the rise in prevalence of …

Background Clinical complexity is common in atrial fibrillation (AF) patients. We assessed
the impact of clinical complexity on oral anticoagulant (OAC) treatment patterns and major …

Background: The randomized EAST-AFNET4 (Early Treatment of Atrial Fibrillation for Stroke
Prevention Trial–Atrial Fibrillation Network) demonstrated that early rhythm control (ERC) …